AKT1 and Down syndrome: In order to identify possible immunological alterations that could contribute to the clinical phenotype of children with Down syndrome, we explored the extent of hyperphosphorylation of the PI3K/AKT signalling pathway and T cell exhaustion and compared this with healthy age-matched individuals.